Our blog includes news from LINQ, information about recent events in the projects we work with, and insights into the markets and funding programmes relevant for our projects.
Core-NB studies the impact of TB and HIV on COVID-19 outcomes
We are delighted to announce that we have just added a new project to the LINQ portfolio, Core-NB, coordinated by Prof Stefan Niemann of Research Center Borstel, Germany.
iMAP: The vision of a world free from heart attacks and stroke
LINQ has been supporting the Cambridge-led iMAP consortium in the planning and preparation of the iMAP proposal. The group of world-leading scientists are set out to make atherosclerosis a disease of the past.
The EUCANCan consortium held its annual meeting on May 20-21. The goal of the meeting was to take stock of the project’s progress to date and discuss upcoming milestones.
EUCANCan and ESPACE hosted joint webinar on January 11, 2021
To jump-start the new year, LINQ’s two projects EUCANCan and ESPACE teamed up to host a joint webinar on January 11, 2021. LINQ organized the webinar ‘New IT approaches in genome analysis,’ which was moderated by Christian Lawerenz of Steinbeis.
TriageTB consortium got together virtually for the Year 1 Meeting in mid-November. Despite intermittent lockdowns and ‘the new normal’ this year, the consortium has managed to stay productive.
On October 20, LINQ coordinated and took part in StatinTB’s Year 2 Progress Meeting, where the consortium discussed the project’s progress to date and made plans for the year ahead.
Ten months into the project, the ESPACE consortium got together virtually on October 22-23, 2020, to discuss past achievements and upcoming milestones.
ESPACE works closely with other H2020-HCA projects
Our project ESPACE is part of the H2020-HCA cluster, in which LINQ plays a central role in encouraging cross-project collaboration. The projects held a joint virtual meeting on September 22.
The European and Developing Countries Clinical Trials Partnership (EDCTP) recently published a video highlighting the work of three of its tuberculosis (TB) projects, including PredictTB.
